Two Sigma Advisers LP Has $20.53 Million Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Two Sigma Advisers LP lifted its position in Teladoc Health, Inc. (NYSE:TDOC) by 213.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,258,711 shares of the health services provider’s stock after acquiring an additional 1,537,094 shares during the period. Two Sigma Advisers LP owned approximately 1.31% of Teladoc Health worth $20,532,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Robeco Institutional Asset Management B.V. raised its position in shares of Teladoc Health by 21.8% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider’s stock valued at $6,365,000 after acquiring an additional 125,111 shares during the period. Nisa Investment Advisors LLC increased its stake in Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock worth $3,874,000 after purchasing an additional 424,180 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Teladoc Health by 18.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock worth $22,213,000 after purchasing an additional 384,528 shares in the last quarter. Geode Capital Management LLC increased its stake in Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock worth $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Finally, Commonwealth Equity Services LLC increased its stake in Teladoc Health by 35.7% during the 4th quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 29,903 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares of the company’s stock, valued at $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.58% of the company’s stock.

Teladoc Health Trading Up 0.3%

NYSE TDOC opened at $7.33 on Wednesday. The company has a market cap of $1.29 billion, a PE ratio of -1.27 and a beta of 1.82. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The stock has a 50 day moving average of $7.52 and a 200-day moving average of $9.34.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, equities research analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on TDOC shares. The Goldman Sachs Group lowered their target price on Teladoc Health from $13.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, May 1st. Wells Fargo & Company lowered their target price on Teladoc Health from $10.00 to $8.00 and set an “equal weight” rating for the company in a research note on Thursday, May 8th. Jefferies Financial Group lowered their target price on Teladoc Health from $10.00 to $8.00 and set a “hold” rating for the company in a research note on Monday, April 21st. Evercore ISI lowered their target price on Teladoc Health from $8.00 to $7.00 and set an “in-line” rating for the company in a research note on Thursday, May 1st. Finally, Canaccord Genuity Group lowered their target price on Teladoc Health from $14.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $9.71.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.